Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial

PaperCitations, authors & open-access status

Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 81 citations, 2020 year and green oa status.

81
Citations
2020
Year
green
OA Status

Related on ScholarIQ

Bruce Neal
Author
Christopher P. Cannon
Author
George L. Bakris
Author
Bernard Zinman
Author
Kenneth W. Mahaffey
Author
American Heart Journal
Journal
470M+ articles · free account